| Literature DB >> 34277161 |
Sachin Patil1, Phillip Beck1, Taylor B Nelson1, Andres Bran1, William Roland1.
Abstract
Herpes simplex virus (HSV), a human alpha herpes virus, is responsible for most infections caused by herpes viruses worldwide. Among the herpes simplex viruses, both HSV 1 and 2 cause significant morbidity. HSV-2 accounts for most genital infections with extragenital complications involving the groin, thigh, or other pelvic areas. HSV-2 is the leading viral cause of sexually transmitted diseases. Viral dissemination via the blood or the cutaneous route during primary infection can affect joints, liver, lungs, spinal cord, and brain. HSV-2, by nature of its higher reactivation frequency, leads to clinical reactivation or subclinical shedding, resulting in increased transmission risk during unprotected sexual encounters. HSV-2 reactivation can result in lesions involving the fingers, skin, eyes, brain, and visceral organs such as the esophagus, lung, and liver. Ocular involvement results in keratitis, blepharitis, conjunctivitis, and rarely necrotizing retinitis. Oculomotor cranial nerve involvement by HSV is a rare entity even in patients with human immunodeficiency virus infection. Clinical features associated with reactivation are seen in primary infections, especially in children and adolescents. A medical literature search resulted in a few cases caused by a varicella-zoster virus but none by HSV. Here we describe a young female with a newly diagnosed meningoencephalitis and abducens nerve palsy (first case) due to a primary HSV infection. She came to the emergency department with headache, confusion, abnormal behavior and later developed diplopia as an inpatient. She was treated successfully with two weeks of acyclovir.Entities:
Keywords: abducens nerve palsy; cranial nerve palsy; encephalitis; herpes simplex virus; meningitis
Year: 2021 PMID: 34277161 PMCID: PMC8269988 DOI: 10.7759/cureus.15523
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
A summary of laboratory and imaging findings
COVID-19 = Coronavirus disease 2019, CSF = Cerebrospinal Fluid, VDRL = Venereal Disease Research Laboratory Test, PCR = Polymerase chain reaction.
| Laboratory test/Others | Result | Laboratory test/Imaging | Result |
| Temperature max | 39.5°C | CSF Color | Clear |
| Complete Blood count | Hemoglobin 11.1 g/dL, Platelet count 263,000/mL | CSF white cell count | 808 |
| Metabolic Panel | normal | CSF Neutrophil % | 12% |
| Hemoglobin A1c | 5.5% (4 – 6) | CSF Monocytes % | 36% |
| Lactic acid | 3.3 mmol/L (0.5 – 2.2) | CSF Lymphocytes % | 52% |
| Creatinine Kinase | 50 units/L (20 – 180) | CSF Red Blood Cell count | 182 |
| Lipid Panel | Within Normal Limits | CSF VDRL | Negative |
| Troponin T | ˂ 0.01 ng/mL | CSF Cryptococcal Antigen test | Negative |
| Thyroid-stimulating hormone level | 3.290 mIU/L (0.27 – 4.2) | CSF Culture | Negative |
| Urine Analysis | Negative for UTI | CSF Bio Fire PCR Panel | Negative |
| Urine Drug Screen | Positive for cannabinoids | CSF HSV 1 & 2 DNA PCR | Positive for HSV-2 DNA |
| Nasopharyngeal COVID-19 PCR | Negative | Blood Culture | Negative |
| Nasopharyngeal Influenza A & B Antigen Testing | Negative | Serum Pregnancy test | Negative |
| HIV 1 & 2 Antigen Antibody testing | Negative | Serum Ferritin | 65.2 ng/mL (13 – 150) |
| Syphilis IgG and IgM testing | Negative | Serum Iron | 14 mcg/dL (37 – 145) |
| TB Gold QuantiFERON | Negative | Chest X-ray | No acute abnormality |
| Ehrlichia chaffeensis / canis / ewingii CSF and Blood PCR | Negative | Computed Tomography of Head | No acute intracranial abnormality |
| Anaplasma Serology | Negative | Magnetic Resonance Imaging of Brain | No acute intracranial abnormality |
Figure 1Normal axial CT scan at the level of the fourth ventricle
Figure 2Normal axial flair T2-weighted MRI at the level of inferior colliculus